Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paravertebral Block With Liposomal Bupivacaine vs Epidural Block for Postoperative Analgesia in Esophageal Surgery
NCT06704698Completed
- Sponsor
- Zhejiang Cancer Hospital
- Start
- Dec 2024
- Primary completion
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of liposomal bupivacaine in postoperative pain (2 arms), sponsored by Zhejiang Cancer Hospital. Primary endpoint: Overall Benefit of Analgesic Score at 3 days. Started Dec 2024; status: completed.
02
Drugs
liposomal bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06704698.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06704698.